L-carnitine supplementation in dialysis patients: Does the evidence justify its use?

Seminars in Dialysis

Volumn 18, Issue 1, 2005, Pages 1-2

  Steinman, Theodore I ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; ERYTHROPOIETIN;

ANEMIA; BLOOD LEVEL; CARNITINE DEFICIENCY; DIALYSIS; DIET SUPPLEMENTATION; ENERGY METABOLISM; GOVERNMENT; HEALTH CARE ORGANIZATION; HEART MUSCLE; HEMODIALYSIS PATIENT; HUMAN; HYPOTENSION; KIDNEY FAILURE; LABORATORY TEST; MEASUREMENT; MEDICAL LITERATURE; METHODOLOGY; MORBIDITY; MORTALITY; POPULATION RESEARCH; REVIEW; SCIENCE; SKELETAL MUSCLE; STANDARD; SYMPTOM;

ANEMIA, HYPOCHROMIC; CARNITINE; DIETARY SUPPLEMENTS; HUMANS; HYPOTENSION; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; VITAMIN B COMPLEX;

EID: 14844328167     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2005.18104.x     Document Type: Review

References (24)

1. Golper TA, Ahmad S: L-carnitine administration to hemodialysis patients: has its time come? Semin Dial 5:94-98, 1992
2. Kopple JD, Wolfson M, Chertow G, Salusky I: Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 35(suppl 2):S54-S55, 2000
3. Thomas S, Fischer FP, Mettang T, Pauli-Magnus C, Weber J, Kuhlmann U: Effects of L-carnitine on leukocyte function and viability in hemodialysis patients: a double-blind randomized trial. Am J Kidney Dis 34:678-687, 1999
4. Siami G, Clinton ME, Mrak R, Griffis J, Stone W: Evaluation of the effect of intravenous L-carnitine therapy on function, structure and fatty acid metabolism of skeletal muscle in patients receiving chronic hemodialysis. Nephron 57:306-313, 1991
5. Kopple JD, Hoppel CL, Casaburi R, Storer T, Sawelson S, Qing DP: Effect of exercise on serum and skeletal muscle carnitine levels in maintenance dialysis patients [abstract]. J Am Soc Nephrol 10:263A, 1999
6. Golper TA, Wolfson M, Ahmad S, Hirschberg R, Kurtin P, Katz LA, Nicora R, Ashbrook D, Kopple JL: Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects. Kidney Int 38:904-911, 1990
7. Ahmad S, Robertson HT, Golper TA, Wolfson M, Kurtin P, Katz LA, Hirschberg R, Nicora R, Ashbrook DW, Kopple JD: Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kidney Int 38:912-918, 1990
8. Centers for Medicare and Medicaid Services. Levo carnitine for end stage renal disease. Report no. CAG-00077N. Baltimore, MD: Centers for Medicare and Medicaid Services, 2002
9. Steinman TI, Nissenson AR, Glassock RJ, Dickmeyer J, Mattern WD, Parker TF III, Hull AR: L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking - or were they? Nephrol News Issues 17:28-39, 2003
10. Vaux EC, Taylor DJ, Altmann P, Rajagopalan B, Graham K, Cooper R, Bonomo Y, Styles P: Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease. Nephron Clin Pract 97:c41-48, 2004
11. Davenport A: Carnitine: a false dawn in the treatment of muscle weakness in end-stage renal failure patients? Nephron Clin Pract 97:c33-34, 2004
12. van Es A, Henny FC, Kooistra MP, Lobatto S, Scholte HR: Amelioration of cardiac function by L-carnitine administration in patients on haemodialysis. Contrib Nephrol 98:28-35, 1992
13. Brass EP, Adler S, Sietsema KE, Hiatt WR, Orlando AM, Amato A: Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients. Am J Kidney Dis 37:1018-28, 2001
14. Savica V, Reda E, D'Iddio S, Calvani M, Santoro D, Bellinghieri G: Dialysis-induced carnitine deficiency: a meta-analysis evaluation of clinical results [abstract]. J Am Soc Nephrol 10:302A, 1999
15. Kooistra MP, Struyvenberg A, van Es A: The response to recombinant human erythropoietin in patients with the anemia of end-stage renal disease is correlated with serum carnitine levels. Nephron 57:127-128, 1991
16. Labonia WD: L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin. Am J Kidney Dis 26:757-764, 1995
17. Patrikarea A, Stamatelow K, Ntaountaki I: The effect of combined L-carnitine and erythropoietin administration on the anaemia and on the lipid profile of patients on hemodialysis [abstract]. Nephrol Dial Transplant 11:A262, 1996
18. Hurot JM, Cucherat M, Haugh M, Fouque D: Effects of L-carnitine supplementation in maintenance hemodialysis patients: a systematic review. J Am Soc Nephrol 13:708-714, 2002
19. Caruso U, Leone L, Cravatto E: Effects of L-carnitine on anemia in aged hemodialysis patients treated with recombinant human erythropoietin: a pilot study. Dial Transplant 27:498-506, 1998
20. Cooper A, Mikhail A, Lethbridge MW, Kemeny DM, Macdougall IC: Pentoxifylline improves hemoglobin levels in patients with erythropoietin- resistant anemia in renal failure. J Am Soc Nephrol 15:1877-82, 2004
21. Tarng DC, Wei YH, Huang TP, Kuo BI, Yang WC: Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. Kidney Int 55:2477-2486, 1999
22. Sezer S, Ozdemir FN, Yakupoglu U, Arat Z, Turan M, Haberal M: Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients. Artif Organs 26:366-370, 2002
23. Shihabi ZK, Oles KS, McCormick CP, Penry JK: Serum and tissue carnitine assay based on dialysis. Clin Chem 38:1414-1417, 1992
24. National Kidney Foundation: Best practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. Presented at the National Kidney Foundation Carnitine Consensus Conference, Chicago, IL, September 8-10, 2002.